Copyright © BusinessAMBE 2023 Key takeaways With the 2.2 billion dollar acquisition of Dynavax, Sanofi is expanding its vaccine portfolio with Heplisav-B and a highly promising shingles vaccine...
Sanofi acquires Dynavax and strengthens its vaccine portfolio
